9WY-28950-99356
3 vaccinations
1 coded response
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 723 / AR
- Registered
- 2021-12-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Dose 1 — Moderna
-
2021-02-23
Dose 2 — Moderna
-
2021-10-22
Dose 3 — Moderna
-
2021-12-09
Registered in v-safe
- 2022-04-22
-
2022-10-24
Survey response — 12 months, dose 3MedDRA: Nausea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: NauseaMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Moderna | No |
| 2 | 2021-02-23 | Moderna | No |
| 3 | 2021-10-22 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 12 — 12 months, dose 3
Symptoms: Nausea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release